← Back to all trials
Recruiting
NCT05635552
All Eyes on PCS - Analysis of the Retinal Microvasculature in Patients With Post-COVID-19 Syndrome
Conditions: Long Covid19, Post COVID-19 Condition, Endothelial Dysfunction
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Enrollment: 300
Sponsor: Technical University of Munich
Location: Germany
Summary
The goal of this observational, prospective study is to in depth analyze the retinal microvasculature in patients with Post-COVID-19 Syndrome (PCS).
The main questions it aims to answer is:Do patients with PCS show a prolonged endothelial dysfunction when compared with fully COVID-19 recovered participants?
Does symptom severity in PCS patients correlate with the extend of endothelial dysfunction?
Do these changes correlate with improvement in symptoms in the prospective observation?
Eligibility Criteria
Inclusion Criteria:Patients with Post-COVID syndrome (positive PCR or positive rapid antibody test ≥3 months) with a currently existing, PCS-typical complaint complex, ongoing for at least 2 months and cannot be explained by an alternative diagnosis.Control group: recovered from COVID-19 infection (positive PCR or positive rapid antibody test ≥ 3 months) without residual symptoms.Healthy cohort: no history of COVID-19 infectionExclusion Criteria:Missing or incomplete consent formAge < 18 yearsPregnancyMalignancyDiseases associated with a significant change in life expectancyAutoimmune diseases of the rheumatological typeCataractEpilepsyGlaucoma
Source: ClinicalTrials.gov (NCT05635552). StuddyBuddy aggregates publicly available trial information.